{"id":"https://openalex.org/W1997248588","doi":"https://doi.org/10.1097/cad.0b013e328340fd02","title":"Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer","display_name":"Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer","publication_year":2010,"publication_date":"2010-11-15","ids":{"openalex":"https://openalex.org/W1997248588","doi":"https://doi.org/10.1097/cad.0b013e328340fd02","mag":"1997248588","pmid":"https://pubmed.ncbi.nlm.nih.gov/21218606"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0b013e328340fd02","doi":"https://doi.org/10.1097/cad.0b013e328340fd02","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0b013e328340fd02","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073742272","display_name":"Javier Sastre","orcid":"https://orcid.org/0000-0001-6538-0065","observed_orcids":["https://orcid.org/0000-0001-6538-0065"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Javier Sastre","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u0131nico San Carlos, 28040 Madrid, Spain. jsastre.hcsc@salud.madrid.org","Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","e-mail: [email\u00a0protected]","fax: +34 91 330 35 44","to Dr Javier Sastre, Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, 28040 Madrid, Spain Tel: +34 91 330 35 46"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u0131nico San Carlos, 28040 Madrid, Spain. jsastre.hcsc@salud.madrid.org","institution_ids":["https://openalex.org/I2961216182"]},{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +34 91 330 35 44","institution_ids":[]},{"raw_affiliation_string":"to Dr Javier Sastre, Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, 28040 Madrid, Spain Tel: +34 91 330 35 46","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074441562","display_name":"Ana Custodio","orcid":"https://orcid.org/0000-0003-1917-5479","observed_orcids":["https://orcid.org/0000-0003-1917-5479"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Custodio","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030931601","display_name":"Juan Carlos S\u00e1nchez","orcid":"https://orcid.org/0000-0002-0321-7905","observed_orcids":["https://orcid.org/0000-0002-0321-7905"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan C. Sanchez","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018676171","display_name":"Luis M Ortega","orcid":"https://orcid.org/0000-0002-7987-8531","observed_orcids":["https://orcid.org/0000-0002-7987-8531"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Ortega","raw_affiliation_strings":["Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104024325","display_name":"Laura Rodr\u00edguez","orcid":"https://orcid.org/0000-0001-7353-5338","observed_orcids":["https://orcid.org/0000-0001-7353-5338"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura Rodriguez","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066684629","display_name":"Javier Puente","orcid":"https://orcid.org/0000-0002-6910-1331","observed_orcids":["https://orcid.org/0000-0002-6910-1331"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Puente","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109937507","display_name":"Juan Antonio Corona","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Corona","raw_affiliation_strings":["Radiotherapy Oncology, Hospital Cl\u00ednico San Carlos, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiotherapy Oncology, Hospital Cl\u00ednico San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038204321","display_name":"Rosario Alfonso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rosario Alfonso","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Manuel de las Heras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel de las Heras","raw_affiliation_strings":["Radiotherapy Oncology, Hospital Cl\u00ednico San Carlos, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiotherapy Oncology, Hospital Cl\u00ednico San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007291981","display_name":"Eduardo D\u00edaz\u2010Rubio","orcid":"https://orcid.org/0000-0003-2792-5348","observed_orcids":["https://orcid.org/0000-0003-2792-5348"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eduardo D\u00edaz-Rubio","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico San Carlos, Center Affiliated to the Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa (RD06/0020/0021), Instituto Carlos III, Spanish Ministry of Science and Innovation","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073742272"],"corresponding_institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2961216182"],"apc_list":null,"apc_paid":null,"fwci":0.4738,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.6661719,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"22","issue":"2","first_page":"185","last_page":"190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13110","display_name":"Colorectal and Anal Carcinomas","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rectal-cancer","display_name":"rectal cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/neoadjuvant-chemoradiotherapy","display_name":"neoadjuvant chemoradiotherapy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/fluoropyrimidine","display_name":"fluoropyrimidine","score":0.9120000004768372},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.8209999799728394},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/risk-adapted-therapy","display_name":"risk-adapted treatment","score":0.8820000290870667},{"id":"https://openalex.org/keywords/local-recurrence","display_name":"local recurrence","score":0.6980000138282776},{"id":"https://openalex.org/keywords/systemic-relapse","display_name":"systemic relapse","score":0.9380000233650208},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9269999861717224},{"id":"https://openalex.org/keywords/downstaging","display_name":"downstaging","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8946126699447632},{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.8377615213394165},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.8023859262466431},{"id":"https://openalex.org/C2779804826","wikidata":"https://www.wikidata.org/wiki/Q45435667","display_name":"Folinic acid","level":4,"score":0.6136395335197449},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6004658937454224},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.5929780602455139},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5670555830001831},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49272921681404114},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.47375303506851196},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.4406333267688751},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3721994161605835},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3395844101905823},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31680959463119507},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.06814870238304138}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018714","descriptor_name":"Radiotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cad.0b013e328340fd02","doi":"https://doi.org/10.1097/cad.0b013e328340fd02","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0b013e328340fd02","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:21218606","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21218606","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1178462535","https://openalex.org/W2921042160","https://openalex.org/W4238755780","https://openalex.org/W4255498346","https://openalex.org/W2097656606","https://openalex.org/W2393314511","https://openalex.org/W2107249978","https://openalex.org/W2011097563","https://openalex.org/W2601551648","https://openalex.org/W1994752990"],"abstract_inverted_index":{"Adjuvant":[0],"chemotherapy":[1],"in":[2,32,81,112,121,162,173,181,186,192,203,273],"rectal":[3],"cancer":[4],"is":[5,22,249],"not":[6],"well":[7],"defined.After":[8],"neoadjuvant":[9,103],"chemoradiation":[10],"and":[11,24,54,56,106,157,168,190,208,218,228,231],"surgery,":[12],"at":[13,198],"least":[14],"a":[15,28,38],"short":[16],"period":[17],"of":[18,41,79,90,115,124,260],"treatment":[19,101],"with":[20,37,102,226,237,251,257,269,276],"5-fluorouracil":[21,73],"recommended,":[23],"some":[25],"investigators":[26],"claim":[27],"more":[29,224,235],"aggressive":[30],"approach,":[31],"particular,":[33],"for":[34,201,280],"those":[35,274],"patients":[36,97,131,138,202,275],"high":[39,277],"risk":[40,91,278],"systemic":[42,161,172],"relapse.":[43],"Nevertheless,":[44],"there":[45],"are":[46,285],"few":[47],"studies":[48],"about":[49],"adjuvant":[50,93,110,164,175,246],"combination":[51,66,120],"therapy":[52,67],"tolerance":[53],"efficacy,":[55],"no":[57,241],"randomized":[58],"trials":[59,284],"have":[60],"been":[61],"conducted":[62],"comparing":[63],"fluoropyrimidines":[64,111,227],"versus":[65],"such":[68],"as":[69,141],"folinic":[70],"acid":[71],"plus":[72,74,160,171],"oxaliplatin(FOLFOX),":[75],"considered":[76],"the":[77,113,122,163,174,187,193,204,258],"standard":[78],"care":[80],"stage":[82],"IIIcolon":[83],"cancer.":[84],"We":[85],"present":[86],"an":[87,252],"institutional":[88],"series":[89],"adapted":[92],"therapy.":[94],"Sixty":[95],"evaluable":[96],"who":[98],"had":[99],"received":[100,109],"fluoropyrimidine":[104],"radiotherapy":[105],"surgery":[107],"now":[108],"case":[114,123],"pT0-2N0":[116],"or":[117,126,143,213],"oxaliplatin":[118,261],"based":[119,262],"pT3-4":[125,142],"N+":[127,144,214],".":[128],"Overall,":[129],"33":[130],"experienced":[132],"downstaging":[133],"to":[134],"pT2-0N0":[135],"(55%)":[136],"and27":[137],"were":[139,216,234,240],"restaged":[140],"(45%)":[145],"after":[146],"surgery.":[147],"Local":[148],"recurrence":[149],"rate":[150],"was":[151,223],"5%":[152],"(three":[153],"patients),":[154],"one":[155,158,169],"local":[156,159,170],"single":[165],"agent":[166],"group":[167,189,211],"FOLFOX":[176,194],"group.":[177,195],"Systemic":[178],"relapse":[179],"occurred":[180],"14":[182],"patients(23.3%),":[183],"five":[184],"(15%)":[185],"single-agent":[188],"nine(33.3%)":[191],"Disease-free":[196],"survival":[197,266],"3":[199],"years":[200],"good":[205],"prognostic":[206,210],"group(pT0-2N0)":[207],"poor":[209],"(pT3-4":[212],")":[215],"78.7":[217],"62.2%,":[219],"respectively.":[220],"Severe":[221],"diarrhoea":[222],"frequent":[225],"neutropenia,":[229],"mucositis":[230],"peripheral":[232],"neuropathy":[233],"common":[236],"FOLFOX.":[238],"There":[239],"toxic":[242],"deaths.":[243],"A":[244],"risk-adapted":[245],"therapeutic":[247],"decision":[248],"feasible":[250],"acceptable":[253],"safety":[254],"profile":[255],"even":[256],"use":[259],"combinations.":[263],"Three-year":[264],"disease-free":[265],"compares":[267],"favourably":[268],"historical":[270],"controls,":[271],"especially":[272],"factors":[279],"relapse.Phase":[281],"III":[282],"controlled":[283],"needed.":[286]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}